Michael Jacobsen
Financieel Directeur/CFO bij OMEROS CORPORATION
Vermogen: 47 040 $ op 31-05-2024
Profiel
Michael A.
Jacobsen is currently the Chief Accounting Officer, Treasurer & VP at Omeros Corp.
He previously worked as the Senior Director-Finance & Corporate Controller at ICOS Corp.
and as the Chief Accounting Officer & Vice President at ZymoGenetics, Inc. He also served as the Secretary, Chief Accounting Officer & VP-Finance at Sarepta Therapeutics, Inc. from 2012 to 2013.
Jacobsen received his undergraduate degree from Idaho State University in 1980.
Bekende belangen in openbare bedrijven
Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
---|---|---|---|---|
OMEROS CORPORATION
0.02% | 25-04-2024 | 14 000 ( 0.02% ) | 47 040 $ | 31-05-2024 |
Actieve functies van Michael Jacobsen
Bedrijven | Functie | Begin |
---|---|---|
OMEROS CORPORATION | Financieel Directeur/CFO | 01-08-2013 |
Eerdere bekende functies van Michael Jacobsen
Bedrijven | Functie | Einde |
---|---|---|
SAREPTA THERAPEUTICS, INC. | Financieel Directeur/CFO | 15-11-2011 |
ZymoGenetics, Inc.
ZymoGenetics, Inc. Pharmaceuticals: MajorHealth Technology ZymoGenetics, Inc. develops protein based drugs. It focuses on the discovery, development, manufacture, and commercialization of therapeutic proteins for the treatment of human diseases, including homeostasis, inflammatory and autoimmune diseases, cancer, and viral infections. The company was founded by Earl W. Davie, Benjamin D. Hall and Michael Smith in 1981 and is headquartered in Seattle, WA. | Operationeel Directeur | 01-08-2011 |
ICOS Corp.
ICOS Corp. Pharmaceuticals: OtherHealth Technology ICOS Corp. manufactures medications to treat inflammation and other serious diseases. It focuses on the development of treatments for unmet medical conditions such as prostatic hyperplasia, hypertension, pulmonary arterial hypertension, cancer, and inflammatory diseases. The company was founded in 1989 by Christopher Henney and George Rathman and is headquartered in Bothell, WA. | Financieel Directeur/CFO | - |
Opleiding van Michael Jacobsen
Idaho State University | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 2 |
---|---|
SAREPTA THERAPEUTICS, INC. | Health Technology |
OMEROS CORPORATION | Health Technology |
Bedrijven in privébezit | 2 |
---|---|
ZymoGenetics, Inc.
ZymoGenetics, Inc. Pharmaceuticals: MajorHealth Technology ZymoGenetics, Inc. develops protein based drugs. It focuses on the discovery, development, manufacture, and commercialization of therapeutic proteins for the treatment of human diseases, including homeostasis, inflammatory and autoimmune diseases, cancer, and viral infections. The company was founded by Earl W. Davie, Benjamin D. Hall and Michael Smith in 1981 and is headquartered in Seattle, WA. | Health Technology |
ICOS Corp.
ICOS Corp. Pharmaceuticals: OtherHealth Technology ICOS Corp. manufactures medications to treat inflammation and other serious diseases. It focuses on the development of treatments for unmet medical conditions such as prostatic hyperplasia, hypertension, pulmonary arterial hypertension, cancer, and inflammatory diseases. The company was founded in 1989 by Christopher Henney and George Rathman and is headquartered in Bothell, WA. | Health Technology |